[DOI] [PMC free article] [PubMed] [Google Scholar] Woo TU, Walsh JP, Benes FM
When the medication is removed, the support it provides begins to fade, which can prompt weight regain
It clearly states that compounded versions are not FDA approved, which is the right disclosure
It is common for the body to eventually adapt to a single-hormone signal like Ozempic, leading to a frustrating weight-loss plateau
The But one The secondary endpoints of examining cardiometabolic risk factors appear promising
For patients on long-term ASMs, supplementation with folic acid, vitamins B12, B6, and D is recommended, though significant intercountry variations exist in folic acid dosing protocols (35)